Nasyrova, Regina F.,
Khasanova, Aiperi K.,
Altynbekov, Kuanysh S.,
Asadullin, Azat R.,
Markina, Ekaterina A.,
Gayduk, Arseny J.,
Shipulin, German A.,
Petrova, Marina M.,
Shnayder, Natalia A. (2022) and new generations as the first-line
treatment of Sch are not
effective in about a third of cases
ТРАНСПЛАНТАЦИОННЫЕ ТЕХНОЛОГИИ В ЛЕЧЕНИИ БУЛЛЕЗНОЙ КЕРАТОПАТИИTRANSPLANTATION TECHNOLOGIES IN THE
TREATMENT OF BULLOUS KERATOPATHY
ATAS, A.E.,
SARAC, A.,
DIRICAN, A.,
TOPBASI, N.,
UZAR, T.,
RASTGAR, L.,
PANKINA, E.,
OZKAYA, S. (2019) in patients with massive PE. Study aim: We aimed to share the results of
thrombolytic
treatment in patients
Survival of patients with lymphoproliferative diseases increases.
For
effective treatment we should